|
Post by lakers on Oct 1, 2017 17:59:29 GMT -5
Tomorrow we will likely learn about items 2, 3, 4 from: Near Term Milestones and Key Events Growth Trajectory Continues for Afrezza FDA Label Change Recapitalization International Expansion Announcements Receptor Life Sciences One Drop Collaboration Expansion of Payor Coverage Completion of STAT Trial (Afrezza+Dexcom IND Filing for Treprostinil Mike mentioned RLS as second pipeline. RLS failed applying for the company name several times. RLS backers are deep pocket. They can pump more money into the combined co. RLS needs the Danbury plant, TS. RLS's backers would acquire the plant, TS if needed. They have vested interest to prop up Mnkd. I would not be surprised if recap includes RLS's backers. Read more: mnkd.proboards.com/user/1882/recent#ixzz4uIi2cqSZ
|
|
|
Post by peppy on Oct 1, 2017 18:09:48 GMT -5
Tomorrow we will likely learn about items 2, 3, 4 from: Near Term Milestones and Key Events Growth Trajectory Continues for Afrezza FDA Label Change Recapitalization International Expansion Announcements Receptor Life Sciences One Drop Collaboration Expansion of Payor Coverage Completion of STAT Trial (Afrezza+Dexcom IND Filing for Treprostinil Mike mentioned RLS as second pipeline. RLS failed applying for the company name several times. RLS backers are deep pocket. They can pump more money into the combined co. RLS needs the Danbury plant, TS. RLS's backers would acquire the plant, TS if needed. They have vested interest to prop up Mnkd. I would not be surprised if recap includes RLS's backers.] Read more: mnkd.proboards.com/user/1882/recent#ixzz4uIi2cqSZ
Mike knew what he was doing when he negotiated the Oct 31, 2017 Deerfield date is my guess.
|
|
|
Post by ptass on Oct 1, 2017 18:11:38 GMT -5
I believe and support this company and it's technology no matter what they say tomorrow. Basically I won't sell until the fat lady sings.
|
|
|
Post by brewguy on Oct 1, 2017 18:12:25 GMT -5
Tomorrow we will likely learn about items 2, 3, 4 from: Near Term Milestones and Key Events Growth Trajectory Continues for Afrezza FDA Label Change Recapitalization International Expansion Announcements Receptor Life Sciences One Drop Collaboration Expansion of Payor Coverage Completion of STAT Trial (Afrezza+Dexcom IND Filing for Treprostinil Mike mentioned RLS as second pipeline. RLS failed applying for the company name several times. RLS backers are deep pocket. They can pump more money into the combined co. RLS needs the Danbury plant, TS. RLS's backers would acquire the plant, TS if needed. They have vested interest to prop up Mnkd. I would not be surprised if recap includes RLS's backers. Read more: mnkd.proboards.com/user/1882/recent#ixzz4uIi2cqSZHow do you know RLS has deep pockets? From what I recall they attempted to but failed to raise $25million (getting around $3M of the 25 million). If they have deep pockets they wouldn't need to raise this money imo
|
|
|
Post by od on Oct 1, 2017 18:42:36 GMT -5
Let's not forget the notion of 'irrational exuberance'...even rational exuberance reality can be disappointing. All the speculation in the universe will not influence what we will learn tomorrow morning. Serenity now.
|
|
|
Post by peppy on Oct 1, 2017 21:08:50 GMT -5
Tomorrow we will likely learn about items 2, 3, 4 from: Near Term Milestones and Key Events Growth Trajectory Continues for Afrezza FDA Label Change Recapitalization International Expansion Announcements Receptor Life Sciences One Drop Collaboration Expansion of Payor Coverage Completion of STAT Trial (Afrezza+Dexcom IND Filing for Treprostinil Mike mentioned RLS as second pipeline. RLS failed applying for the company name several times. RLS backers are deep pocket. They can pump more money into the combined co. RLS needs the Danbury plant, TS. RLS's backers would acquire the plant, TS if needed. They have vested interest to prop up Mnkd. I would not be surprised if recap includes RLS's backers. Read more: mnkd.proboards.com/user/1882/recent#ixzz4uIi2cqSZ How do you know RLS has deep pockets? From what I recall they attempted to but failed to raise $25million (getting around $3M of the 25 million). If they have deep pockets they wouldn't need to raise this money imo quote: How do you know RLS has deep pockets? reply: Arthur Rubinfeld is involved. www.google.com/search?q=arthur+rubinfeld+starbucks&sa=X&ved=0ahUKEwjGjJ3T6tDWAhVCwlQKHSC8BKoQ1QIIaygA&biw=1366&bih=599
quote: From what I recall they attempted to but failed to raise $25million (getting around $3M of the 25 million). If they have deep pockets they wouldn't need to raise this money imo reply: that was one interpretation. my interpretation, was they raised the money so quickly that some presentations were canceled.
|
|
|
Post by ilovekauai on Oct 1, 2017 21:22:33 GMT -5
WoW! How do you like them Pineapples!!! It's Showtime Crew. Tomorrow we Longs win a great battle. The war is by no means over, but tomorrow is Stalingrad for the Shorts! I just checked in to our site on a whim this evening expecting nothing on a Sunday, and bam...this wonderful news hits. We got this. That's what I'm talking about. The "Trend" (right KC!), is finally going to head north and in the end we win this war. Maybe not right away, but this is epic tomorrow. Onwards! Aloha.
|
|
|
Post by wgreystone on Oct 1, 2017 21:31:55 GMT -5
It must be label change. Mannkind received the result from FDA and it has to announce it before Monday's market openning. Otherwise, there is no need to hold the conference call so early.
|
|
|
Post by bones1026 on Oct 1, 2017 21:48:36 GMT -5
Tomorrow we will likely learn about items 2, 3, 4 from: Near Term Milestones and Key Events Growth Trajectory Continues for Afrezza FDA Label Change Recapitalization International Expansion Announcements Receptor Life Sciences One Drop Collaboration Expansion of Payor Coverage Completion of STAT Trial (Afrezza+Dexcom IND Filing for Treprostinil Mike mentioned RLS as second pipeline. RLS failed applying for the company name several times. RLS backers are deep pocket. They can pump more money into the combined co. RLS needs the Danbury plant, TS. RLS's backers would acquire the plant, TS if needed. They have vested interest to prop up Mnkd. I would not be surprised if recap includes RLS's backers. Read more: mnkd.proboards.com/user/1882/recent#ixzz4uIi2cqSZHow do you know RLS has deep pockets? From what I recall they attempted to but failed to raise $25million (getting around $3M of the 25 million). If they have deep pockets they wouldn't need to raise this money imo In a perfect world, where everything starts going our way..that was orchestrated by Mike and team to simply throw off the shorts..that they barely had the 1M payment in Dec...when in reality the million came from someone like Paul Allen..who happend to have that is his that cash in his pocket
|
|
|
Post by od on Oct 1, 2017 21:52:08 GMT -5
It must be label change. Mannkind received the result from FDA and it has to announce it before Monday's market openning. Otherwise, there is no need to hold the conference call so early. Probably, but why a pre-market conference call? A press release would have been fine, perhaps followed by a call after close. I am not suggesting negative news, but no surprise if more/other than FDA decision.
|
|
|
Post by mytakeonit on Oct 1, 2017 21:59:29 GMT -5
Like I said ... it's a done deal.
I'm not waking up at 3 AM!!! to hear it. I will be sleeping on my shares.
|
|
|
Post by humann on Oct 1, 2017 22:09:52 GMT -5
Looking forward to some good news!
|
|
|
Post by mnkdnewbie on Oct 1, 2017 22:14:00 GMT -5
Anyone else going to try and buy more premarket?
|
|
|
Post by boytroy88 on Oct 1, 2017 22:18:39 GMT -5
Anyone else going to try and buy more premarket? The thought did cross my mind...still debating...might just let it go before the CC if I do...just to play the momentum.
|
|
|
Post by buyitonsale on Oct 1, 2017 22:30:56 GMT -5
I would love a positive PR pre market but not sure about CC scheduled on top of that.
It feels different but maybe fhis time it’s really different!
In a good way!
GLTAL
|
|